Skip to main content
Log in

Anthracyclines: increase in cardiotoxicity increases costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Choi JC, Chang JD, Seal B, Tangirala M, Mullins CD.Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in the United States. 45th Annual Meeting of the American Society of Clinical Oncology: 49 abstr. 1037, 1 Jun 2009. Available from: URL: http://www.abstract.asco.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anthracyclines: increase in cardiotoxicity increases costs. Pharmacoecon. Outcomes News 580, 4 (2009). https://doi.org/10.2165/00151234-200905800-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905800-00011

Keywords

Navigation